CASE STUDIES
Recon is not a place to bring your cookie-cutter assignments. We like to work on difficult strategy questions and each of our projects is bespoke. That said, we have the domain knowledge and process expertise that comes from having worked on hundreds of projects across all healthcare sectors. Here is a sample of “sanitized” case examples.
A private equity investor weighing a bet on a novel delivery platform needed to know whether scientific novelty would convert into commercial value.
Subcutaneous biologics platform investment
A large pharma health-tech arm needed to understand why its decentralized-trial tools weren't landing with users and how to find a defensible point of differentiation.
Clinical research product roadmap
A gene therapy biotech with a novel approach to a fast-moving disease area needed an objective read on the opportunity and on whether it had a credible path to win there.
Crowded market entry decision
A top biopharma had just acquired a late-stage asset whose target reached well beyond the lead indication and needed to know fast which expansion bets were worth funding.
Post-acquisition indication expansion
A pre-commercial biopharma needed to know where its lead asset belonged in the treatment sequence once two new therapies arrived and what evidence would lead payers to cover it.
Pre-launch market access planning
A contract manufacturer needed a full strategy refresh for the decade ahead: markets to serve, capabilities to build, and the cost to get there.
Contract manufacturing service prioritization
A clinical-stage biotech needed near-term value inflection beyond its lead asset and a defensible short-list to put in front of its board.
Biotech BD in-licensing
